Skip to main content
. 2016 Nov 30;514(1):229–237. doi: 10.1016/j.ijpharm.2016.07.002

Table 1.

Conditions of the HPLC methods used.

Conditions Method 1
(USP34)
Method 2
(in-house)
Apparatus Chromatopac LC-10AS pump, ESA temperature-controlled autosampler and SPD-10 UV detector
(Shimadzu, Kyoto, Japan)
Agilent 1100 series with auto-sampler and UV–vis detector (Agilent, Santa Clara, CA, USA)
Stationary phase C18 Synergi Hydro 4 μm column (150 × 3.9 mm)a C18 Luna 3 μm column
(150 × 4.6 mm)a
Mobile phase Water: acetonitrile: H3PO4
85:15:0.1 (v/v)
50 mM NaH2PO4: Acetonitrile
60:40 (v/v); pH 3
Internal standard (IS) Phenacetin
Flow rate (ml/min) 1 0.6
Detection wavelength (nm) 237 220
Temperature (°C) 25 °C Ambient
Injection volume (μl) 50 40
Thalidomide retention time (min) 18 (24 for IS) 4.8
a

Supplied by Phenomenex (Torrance, CA, USA).